Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04788693
Other study ID # 1557673
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 2025
Est. completion date December 2026

Study information

Verified date May 2024
Source University of Valencia
Contact Constanza San Martín, PhD.
Phone 963864768
Email constanza.martin@uv.es
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to determine whether gait physiotherapy combined with motor imagery exercises has a superior effect on the biomechanics of gait, functionality in activities of daily living, motor capacity, and the perception of the quality of life in people with Parkinson's disease, than gait physiotherapy without motor imagery. To do this, a six-week training program will be carried out twice a week, where walking exercises and motor imaging will be performed in the experimental group while walking exercises only, will be performed in the control group. Motor imagery exercises consist of developing a mental exercise by which an individual rehearses or simulates a given action. We hypothesize that participants who perform motor imagery exercises have better results than participants who train without imagery exercises.


Description:

Background: Motor imagery (MI) is a novel technique in neurorehabilitation. Current evidence supports the ability of people diagnosed with Parkinson's disease (PD) to carry out this technique. However, the trials that assess its effectiveness in this pathology are scarce. In some physical rehabilitation programs, MI is introduced to conventional treatment or, MI can be combined with observation of images or neurofeedback. At present, the effect of this technique has been studied in highly heterogeneous variables, including both motor and cognitive abilities or performance of activities of daily living. The evidence seems to indicate that the introduction of MI to conventional treatment, with an adequate dose, may induce greater benefits over people with PD in early stages (I-III on the Hoehn and Yahr scale), especially in daily actions and movements functional such as gait, regardless of medication. However, the small sample size of the trials and the use of non-validated scales and non-objective tests, make it necessary that the results be viewed with caution. On the other hand, the cost-benefit ratio of the therapy, its benefits and its easy application are significant factors to take into account when adding MI to physiotherapy treatment in people with PD. General objective: To determine whether gait training combined with MI exercises has a superior effect on the biomechanics of gait, functionality in activities of daily living, motor capacity, and the perception of the quality of life in people with PD, which gait training without MI. Specific objectives: 1. To study the validity of the instrumental technique available for the evaluation of gait and the intra- and inter-rater reliability with the same tool in healthy subjects. 2. To check the effect, in the short and medium-term, of a gait training program combined with MI in people diagnosed with PD. 3. To compare the effects of the gait and MI training program with the effects obtained through a gait rehabilitation program without MI exercises. 4. To contrast the gait pattern of people with PD before and after undergoing a rehabilitation program with MI, with that of healthy older people of the same age, sex, and height. 5. To observe the differences in the biomechanics of gait between the hemibody most affected by the signs of PD and the hemibody with less clinical alteration, before and after performing a gait training program combined with MI exercises. Materials and Method: The evaluation session will be carried out three times: before the treatment, at the end of the intervention, and 8-weeks after the intervention has finished. In each evaluation session, a clinical and biomechanical measurement will be carried out. The biomechanical evaluation will be done using 7 inertial sensors in a 10-meter walk corridor. The inertial sensor or inertial measurement unit (IMU) is made up of three different sensors: gyroscope, accelerometer, and magnetometer, capable of collecting information on the turns, linear acceleration, and magnetic north with respect to the earth's magnetic field. The part of the clinical evaluation includes the assessment of the functionality in the activities of daily living, the motor capacity, and the perception of the quality of life through different questionnaires and assessment scales. Intervention: Both, the experimental and control groups of this study, will perform an identical gait physiotherapy program, however, motor imagery exercises will be included in the experimental group. The gait exercises are aimed at improving specific gait characteristics, so they will include: - Exercises for length stride: walk with visual cues on the ground to reach a certain stride length, walk with horizontal poles at a height of 2 cm, walk over steps, treadmill walk. - Exercises for Cadence training using a metronome. - Exercises for gait velocity training by combining the visual and auditory feedback provided in previous exercises and on the treadmill - Exercises for kinematic milestones during the stance and oscillation phase of gait through the mobility of the ankle, knee, and hip joints. The motor imagery exercises will be performed in supine position on a stretcher, before each gait exercise. The instructions will be administered through the physiotherapy voice. The participant with closed eyes imagines himself performing the gait task while the general guidelines that guide the cognitive process are given. The instructions describe how the person is from the starting position and the different body movements that he must pay attention to during the imagining process. Through the instructions, the participant creates an image of himself and perceives the kinesthesia while performing the exercise. The duration of each motor imagery exercise is 8 minutes.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 74
Est. completion date December 2026
Est. primary completion date December 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility The inclusion criteria are: 1. Diagnosed with PD according to the United Kingdom Parkinson's Disease Society Brain Bank diagnostic scale 2. Independent walk in a 10-meter corridor 3. Normal cognitive state, determined by the Mini-Mental State Examination with a score >25 4. Stable medication from the month before the start of the study until the t2 assessment. Likewise, the exclusion criteria are: 1. Additional neurological condition different from PD 2. Disease or musculoskeletal acute alteration that limits mobility or balance 3. Lower extremities asymmetries >1 cm 4. Report pain on the Visual Analog Scale 5. Suffer from blindness, deafness, or any other visual/hearing impairment or pathology that may influence the ability to understand instructions and carry them out 6. Significant tremor that may interrupt the MI exercise 7. To perform other physical therapies or sports during the trial or the two months before.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Physical rehabilitation of gait with motor imagery
Physical rehabilitation of gait is a type of non-invasive treatment that seeks to change the way of performing a task or motor function (in this case, gait) through movement modification and corrected repeated practice, taking into account the alterations, limitations and considerations related to the disease suffered by the person. In this intervention, in addition to physical exercise to correct gait, mental exercises will be included in which the patient visualizes himself performing the exercises that he will then develop with the body.
Physical rehabilitation of gait without motor imagery
Physical rehabilitation of gait is a type of non-invasive treatment that seeks to change the way of performing a task or motor function (in this case, gait) through movement modification and corrected repeated practice, taking into account the alterations, limitations and considerations related to the disease suffered by the person. Motor imagery exercises are not included in this program.

Locations

Country Name City State
Spain University of Valencia Valencia

Sponsors (2)

Lead Sponsor Collaborator
University of Valencia Asociación Parkinson Valencia

Country where clinical trial is conducted

Spain, 

References & Publications (8)

Bek J, Gowen E, Vogt S, Crawford TJ, Poliakoff E. Combined action observation and motor imagery influences hand movement amplitude in Parkinson's disease. Parkinsonism Relat Disord. 2019 Apr;61:126-131. doi: 10.1016/j.parkreldis.2018.11.001. Epub 2018 Nov 9. No abstract available. — View Citation

Bek J, Webb J, Gowen E, Vogt S, Crawford TJ, Sullivan MS, Poliakoff E. Patients' Views on a Combined Action Observation and Motor Imagery Intervention for Parkinson's Disease. Parkinsons Dis. 2016;2016:7047910. doi: 10.1155/2016/7047910. Epub 2016 Sep 29. — View Citation

Bezerra PT, Santiago LM, Silva IA, Souza AA, Pegado CL, Damascena CM, Ribeiro TS, Lindquist AR. Action observation and motor imagery have no effect on balance and freezing of gait in Parkinson's disease: a randomized controlled trial. Eur J Phys Rehabil Med. 2022 Oct;58(5):715-722. doi: 10.23736/S1973-9087.22.07313-0. Epub 2022 Sep 1. — View Citation

Braun S, Beurskens A, Kleynen M, Schols J, Wade D. Rehabilitation with mental practice has similar effects on mobility as rehabilitation with relaxation in people with Parkinson's disease: a multicentre randomised trial. J Physiother. 2011;57(1):27-34. doi: 10.1016/S1836-9553(11)70004-2. — View Citation

Santiago LM, de Oliveira DA, de Macedo Ferreira LG, de Brito Pinto HY, Spaniol AP, de Lucena Trigueiro LC, Ribeiro TS, de Sousa AV, Piemonte ME, Lindquist AR. Immediate effects of adding mental practice to physical practice on the gait of individuals with — View Citation

Scarpina F, Magnani FG, Tagini S, Priano L, Mauro A, Sedda A. Mental representation of the body in action in Parkinson's disease. Exp Brain Res. 2019 Oct;237(10):2505-2521. doi: 10.1007/s00221-019-05608-w. Epub 2019 Jul 20. — View Citation

Subramanian L, Morris MB, Brosnan M, Turner DL, Morris HR, Linden DE. Functional Magnetic Resonance Imaging Neurofeedback-guided Motor Imagery Training and Motor Training for Parkinson's Disease: Randomized Trial. Front Behav Neurosci. 2016 Jun 8;10:111. doi: 10.3389/fnbeh.2016.00111. eCollection 2016. — View Citation

Tamir R, Dickstein R, Huberman M. Integration of motor imagery and physical practice in group treatment applied to subjects with Parkinson's disease. Neurorehabil Neural Repair. 2007 Jan-Feb;21(1):68-75. doi: 10.1177/1545968306292608. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Gait velocity at the post-training time (primary time point) Distance traveled by the body per unit of time at self-selected or comfortable speed, in the direction considered. It is expressed in meters per second (m / s). 6 weeks
Secondary Maximum gait velocity Distance traveled by the body per unit of time at the maximum possible speed, in the direction considered. It is expressed in meters per second (m/s). 6 weeks
Secondary Gait speed variability It is calculated through the coefficient of variation ([standard deviation/mean] Ă— 100) of gait velocity. Indicates how stable or repeatable the participants are when walking. 6 weeks
Secondary Stride length Distance measured between two consecutive supports points of the same foot; the heel strike is the reference used. It is expressed in meters (m). 6 weeks
Secondary Speed variability Variability of walking speed estimated from the repetitions performed at each measurement time. 6 weeks
Secondary Support/ Stance time (s) Time elapsed while the support or stance phase of the gait cycle is developed. It is expressed as a percentage of the total walking cycle. 6 weeks
Secondary Cadence (steps/min) Number of steps executed in a time interval, its most commonly adopted unit being the step per minute. 6 weeks
Secondary Swing time Time elapsed while the swing phase develops. It is expressed as a percentage according to the entire walking cycle. 6 weeks
Secondary Range of motion of lower limb joint (°) Kinematic outcome that represents the range of motion in the sagittal plane of the hip, knee, and ankle joints performed during the gait cycle. These parameters will be specified for each limb (right and left). 6 weeks
Secondary Maximum ankle dorsiflexion during swing (°) Kinematic outcome; Maximum ankle dorsiflexion angle reached during the swing phase, expressed in degrees. 6 weeks
Secondary Maximum knee flexion during swing (°) Kinematic outcome; Maximum knee flexion angle reached during the swing phase, expressed in degrees. 6 weeks
Secondary Maximum hip extension during stance (°) Kinematic outcome; Maximum hip extension angle reached during the stance phase, expressed in degrees. 6 weeks
Secondary Maximum hip flexion during swing (°) Kinematic outcome; Maximum hip flexion angle reached during the swing phase, expressed in degrees. 6 weeks
Secondary Weight-acceptance Ground Reaction Force (Newton, N; Weight%) Kinetic outcome; First force peak of vertical vector of the ground reaction forces during the stance phase of the gait cycle, which corresponds to the maximum reception of weight on the foot that initiates the gait cycle. 6 weeks
Secondary Midstance Ground Reaction Force (Newton, N; Weight%) Kinetic outcome; Lowest force point of the valley located between both maximum force peaks of the vertical vector of the ground reaction forces, which corresponds to the swing of the opposite leg during the gait cycle. 6 weeks
Secondary Push-off Ground Reaction Force (Newton, N; Weight%) Kinetic outcome; Second and last force peak of the vertical vector of the ground reaction forces during the stance phase of the gait cycle, which corresponds to the beginning of takeoff of the foot during the last part of the stance phase. 6 weeks
Secondary Breaking Ground Reaction Force (Newton, N; Weight%) Kinetic outcome; First maximum force peak of the antero-posterior vector of the ground reaction forces during the gait cycle that corresponds to the braking of the foot on the ground. 6 weeks
Secondary Propulsion Ground Reaction Force (Newton, N; Weight%) Kinetic outcome; Second maximum force peak of the antero-posterior vector of the ground reaction forces during the gait cycle that corresponds to the propulsion of the foot on the ground at the end of the stance phase. 6 weeks
Secondary self-referred Quality of Life with the Schwab & England scale Schwab & England scale score 6 weeks
Secondary self-referred Quality of Life with the PDQ-39 questionnaire Parkinson's Disease Questionnaire-39 score 6 weeks
Secondary Freezing of gait Freezing of gait Questionnaire score 6 weeks
Secondary Gait qualitative performance with TMT Tinetti mobility test - Gait section score 6 weeks
Secondary Gait qualitative performance with DYPAGS Dynamic Parkinson Gait Scale score 6 weeks
Secondary Balance qualitative performance with the TMT Tinetti mobility test - Balance section score 6 weeks
Secondary Balance qualitative performance with the MiniBest MiniBest test score 6 weeks
Secondary Mobility Time taken to perform Timed-up and go test (s) 6 weeks
See also
  Status Clinical Trial Phase
Completed NCT05415774 - Combined Deep Brain Stimulation in Parkinson's Disease N/A
Recruiting NCT04691661 - Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease Phase 2
Active, not recruiting NCT05754086 - A Multidimensional Study on Articulation Deficits in Parkinsons Disease
Completed NCT04045925 - Feasibility Study of the Taïso Practice in Parkinson's Disease N/A
Recruiting NCT04194762 - PARK-FIT. Treadmill vs Cycling in Parkinson´s Disease. Definition of the Most Effective Model in Gait Reeducation N/A
Completed NCT02705755 - TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH) Phase 2
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT05830253 - Free-living Monitoring of Parkinson's Disease Using Smart Objects
Recruiting NCT03272230 - Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System N/A
Recruiting NCT06139965 - Validity and Reliability of the Turkish Version of the Comprehensive Coordination Scale in Parkinson's Patients
Completed NCT04580849 - Telerehabilitation Using a Dance Intervention in People With Parkinson's Disease N/A
Completed NCT03980418 - Evaluation of a Semiconductor Camera for the DaTSCAN™ Exam N/A
Completed NCT04477161 - Effect of Ketone Esters in Parkinson's Disease N/A
Completed NCT04942392 - Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic N/A
Terminated NCT03446833 - LFP Beta aDBS Feasibility Study N/A
Completed NCT03497884 - Individualized Precise Localization of rTMS on Primary Motor Area N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT04997642 - Parkinson's Disease and Movement Disorders Clinical Database
Completed NCT04117737 - A Pilot Study of Virtual Reality and Antigravity Treadmill for Gait Improvement in Parkinson N/A
Recruiting NCT03618901 - Rock Steady Boxing vs. Sensory Attention Focused Exercise N/A